Decatur Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,677
| Closed | -$2.81M | – | 53 |
|
|
2024
Q3 | $2.81M | Buy |
2,677
+3
| +0.1% | +$3.34K | 1.3% | 23 |
|
|
2024
Q2 | $2.81M | Buy |
2,674
+69
| +3% | +$66.9K | 1.36% | 21 |
|
|
2024
Q1 | $2.51M | Sell |
2,605
-25
| -1% | -$23.8K | 1.36% | 21 |
|
|
2023
Q4 | $2.31M | Buy |
2,630
+191
| +8% | +$157K | 1.38% | 21 |
|
|
2023
Q3 | $2.01M | Hold |
2,439
| – | – | 1.45% | 19 |
|
|
2023
Q2 | $1.75M | Sell |
2,439
-34
| -1% | -$26.2K | 1.2% | 29 |
|
|
2023
Q1 | $2.03M | Sell |
2,473
-473
| -16% | -$357K | 1.53% | 18 |
|
|
2022
Q4 | $2.13M | Hold |
2,946
| – | – | 1.53% | 21 |
|
|
2022
Q3 | $2.03M | Hold |
2,946
| – | – | 1.54% | 16 |
|
|
2022
Q2 | $1.74M | Hold |
2,946
| – | – | 1.29% | 28 |
|
|
2022
Q1 | $2.06M | Buy |
2,946
+286
| +11% | +$181K | 1.2% | 25 |
|
|
2021
Q4 | $1.68M | Buy |
+2,660
| New | +$1.64M | 1% | 34 |
|
|
2017
Q2 | – | Sell |
-1,217
| Closed | -$472K | – | 72 |
|
|
2017
Q1 | $472K | Buy |
+1,217
| New | +$451K | 0.09% | 56 |
|
|
2015
Q4 | – | Sell |
-1,025
| Closed | -$477K | – | 105 |
|
|
2015
Q3 | $477K | Buy |
+1,025
| New | +$550K | 0.07% | 97 |
|
|
2015
Q2 | – | Sell |
-7,425
| Closed | -$3.35M | – | 102 |
|
|
2015
Q1 | $3.35M | Hold |
7,425
| – | – | 0.42% | 56 |
|
|
2014
Q4 | $3.05M | Sell |
7,425
-8,325
| -53% | -$3.27M | 0.41% | 55 |
|
|
2014
Q3 | $5.68M | Buy |
15,750
+4,775
| +44% | +$1.6M | 0.95% | 37 |
|
|
2014
Q2 | $3.1M | Buy |
+10,975
| New | +$3.25M | 0.58% | 70 |
|
|
2014
Q1 | – | Sell |
-12,660
| Closed | -$3.48M | – | 99 |
|
|
2013
Q4 | $3.48M | Sell |
12,660
-525
| -4% | -$151K | 0.67% | 62 |
|
|
2013
Q3 | $4.13M | Sell |
13,185
-13,000
| -50% | -$3.42M | 0.87% | 55 |
|
|
2013
Q2 | $5.89M | Buy |
+26,185
| New | +$6.1M | 2.04% | 15 |
|
Other funds holding REGN
